Optimum Investment Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Optimum Investment Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$478.3 - $607.98 $220,018 - $279,670	-460 Reduced 85.98%	75 $36,000
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $66,598 - $86,929	135 Added 33.75%	535 $334,000
Q1 2020 Apr 21, 2020	BUY	$336.18 - $494.43 $84,045 - $123,607	250 Added 166.67%	400 $195,000
Q4 2019 Jan 22, 2020	BUY	$274.13 - $376.51 $41,119 - $56,476	150 New	150 $56,000
Q2 2018 Oct 05, 2018	SELL	$284.6 - $344.99 $52,651 - $63,823	-185 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $58,426 - $72,849	185 New	185 $64,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.